Table 1.
Peptides | *Properties | References |
---|---|---|
Transferrin and anti transferrin antibody | Iron binding proteins found in vertebrates. Enables 2-fold increase in tissue accumulation of non-specific antibody conjugated liposome. | [39,40,60–62] |
Herceptin™/Trastuzumab | Antibody against HER2. Showed increased internalization of carrier and a 6-fold increase in internalization. | [50,64,65] |
GE11 peptide | Ligand for human epidermal growth factor receptor. Contains the peptide sequence ‘YHWYGYTPQNVI.’ | [49,51] |
Albumin | Human plasma protein soluble in water. Assists in transporting hydrophobic molecules. Used as a carrier for anticancer therapy. | [12,57,72,147] |
HIV TAT peptide | The TAT protein enters cells when added exogenously. The transduction domain responsible for this property is RKKRRQRRR,’ which can be appended to other systems. | [148–150] |
NGR peptide | This motif has 2 distinct binding sites 1) Aminopeptidase N (CD13) 2) αvβ3 Integrin. Plays a major role in cell adhesion. | [69,71] |
RGD peptide | This motif is a recognized by integrins and is important for cell adhesion. | [66–68,151] |
GFLG peptide | Acts as a cleavable peptide linker sensitive to proteolyses by lysosomal cathepsin B. | [73] |
ALAL peptide | Acts as a cleavable peptide linker sensitive to proteolyses by lysosomal cathepsin B. | [72] |
GPQGaAGQR peptide | Where a = Leucine, Isoleucine or Valine. This peptide sequence acts as a substrate for MMP-2,9 and can be used as a linker/trigger for drug release from polymer conjugates or drug carriers. | [76,79] |
A=Alanine, F=Phenylalanine, G=Glycine, H=Histidine, I=Isoleucine, K=Lysine, L=Leucine, N=Asparaginine, P=Proline, Q=Glutamine, R=Arginine, T=Theronine, V=Valine, W=Tryptophan Y=Tyrosine.